Focusing on sensitization and pain caused by abnormal microglia activation, modulating the TRPV1 channel, inhibiting microglia overactivation, and repairing neural sensitization may be a promising strategy for treating nociplastic pain in RA. Here, TRPV1 is linked to rheumatoid arthritis.